Gender and Cataract – The Role of Estrogen

References

• Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology 1992;99:546–552
   PubMed Web of Science ®Google Scholar
• Leske MC, Connell AM, Wu SY, Hyman L, Schachat A. Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol 1997;115:105–111
   PubMedGoogle Scholar
• Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 1997;104:581–588
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–618
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 1990;97:1428–1433
   PubMed Web of Science ®Google Scholar
• Chew EY, Kim J, Sperduto RD, Datiles MB, 3rd Coleman HR, Thompson DJ, et al. Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31. Ophthalmology 2010;117:2112–2119
   Google Scholar
• Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993;111:831–836
   PubMed Web of Science ®Google Scholar
• Hall AB, Thompson JR, Deane JS, Rosenthal AR. LOCS III versus the Oxford Clinical Cataract Classification and Grading System for the assessment of nuclear, cortical and posterior subcapsular cataract. Ophthalmic Epidemiol 1997;4:179–194
   PubMedGoogle Scholar
• Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17–32
   PubMed Web of Science ®Google Scholar
• Carlsson B, Sjostrand J. Increased incidence of cataract extractions in women above 70 years of age. A population based study. Acta Ophthalmol Scand 1996;74:64–68
   Google Scholar
• Lundstrom M, Stenevi U, Thorburn W. Gender and cataract surgery in Sweden 1992–1997. A retrospective observational study based on the Swedish National Cataract Register. Acta Ophthalmol Scand 1999;77:204–208
   Google Scholar
• Ostberg A, Loth A, Gustafson D, Lindblom B. Skovde cataract study: I. Prevalence of lens opacities in a Swedish community. Ophthalmology 2006;113:970–975
   PubMed Web of Science ®Google Scholar
• Zhang JS, Xu L, Wang YX, You QS, Wang JD, Jonas JB. Five-year incidence of age-related cataract and cataract surgery in the adult population of greater Beijing: the Beijing Eye Study. Ophthalmology 2011;118:711–718
   Google Scholar
• Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population. Ophthalmology 1992;99:546–552
   PubMed Web of Science ®Google Scholar
• Gollogly HE, Hodge DO, St Sauver JL, Erie JC. Increasing incidence of cataract surgery: Population-based study. J Cataract Refract Surg 2013;39:1383–1389
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE. Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. Ophthalmology 2002;109:2052–2057
   PubMed Web of Science ®Google Scholar
• Koo E, Chang JR, Agron E, Clemons TE, Sperduto RD, Ferris FL,3rd et al. Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33. Ophthalmic Epidemiol 2013;20:71–81
   Web of Science ®Google Scholar
• Lundstrom M, Barry P, Henry Y, Rosen P, Stenevi U. Participation in the EUREQUO database report. J Cataract Refract Surg 2012;38:1510
   Google Scholar
• Lundstrom M, Stenevi U, Thorburn W. The Swedish National Cataract Register: a 9-year review. Acta Ophthalmol Scand 2002;80:248–257
   PubMedGoogle Scholar
• Olofsson P, Lundstrom M, Stenevi U. Gender and referral to cataract surgery in Sweden. Acta Ophthalmol Scand 2001;79:350–353
   Google Scholar
• Monestam E, Wachtmeister L. Cataract surgery from a gender perspective – a population based study in Sweden. Acta Ophthalmol Scand 1998;76:711–716
   Google Scholar
• Smirthwaite G, Lundstrom M, Albrecht S, Swahnberg K. Indication criteria for cataract extraction and gender differences in waiting time. Acta Ophthalmol 2013 [Epub ahead of print]
   Google Scholar
• Lewallen S, Courtright P. Gender and use of cataract surgical services in developing countries. Bulletin of the World Health Organization 2002;80:300–303
   PubMed Web of Science ®Google Scholar
• Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol 2001;8:39–56
   PubMedGoogle Scholar
• Lewallen S, Mousa A, Bassett K, Courtright P. Cataract surgical coverage remains lower in women. Br J Ophthalmol 2009;93:295–298
   PubMed Web of Science ®Google Scholar
• Chang JR, Koo E, Agron E, Hallak J, Clemons T, Azar D, et al. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. Ophthalmology 2011;118:2113–2119
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Nemesure B, Yang L, Hennis A. Nine-year incidence of lens opacities in the Barbados Eye Studies. Ophthalmology 2004;111:483–490
   PubMed Web of Science ®Google Scholar
• McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol 1999;128:446–465
   PubMed Web of Science ®Google Scholar
• Hennis A, Wu SY, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004;122:525–530
   PubMedGoogle Scholar
• Storey P, Munoz B, Friedman D, West S. Racial differences in lens opacity incidence and progression: the Salisbury Eye Evaluation (SEE) study. Invest Ophthalmol Vis Sci 2013;54:3010–3018
   PubMed Web of Science ®Google Scholar
• Richter GM, Torres M, Choudhury F, Azen SP, Varma R. Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study. Ophthalmology 2012;119:547–554
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 1986;124:916–925
   PubMed Web of Science ®Google Scholar
• Hollows F, Moran D. Cataract – the ultraviolet risk factor. Lancet 1981;2:1249–1250
   PubMed Web of Science ®Google Scholar
• Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319:1429–1433
   PubMed Web of Science ®Google Scholar
• Sasaki H, Kawakami Y, Ono M, Jonasson F, Shui YB, Cheng HM, et al. Localization of cortical cataract in subjects of diverse races and latitude. Invest Ophthalmol Vis Sci 2003;44:4210–4214
   Google Scholar
• Schein OD, West S, Munoz B, Vitale S, Maguire M, Taylor HR, et al. Cortical lenticular opacification: distribution and location in a longitudinal study. Invest Ophthalmol Vis Sci 1994;35:363–366
   PubMed Web of Science ®Google Scholar
• Duquia RP, Menezes AM, Almeida HL, Jr Reichert FF, Santos Ida S, Haack RL, et al. Prevalence of sun exposure and its associated factors in southern Brazil: a population-based study. Anais brasileiros de dermatologia 2013;88:554–561
   Google Scholar
• Klein BE, Cruickshanks KJ, Klein R. Leisure time, sunlight exposure and cataracts. Documenta ophthalmologica. Advances in ophthalmology 1994;88:295–305
   Google Scholar
• Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation exposure among outdoor workers: state of the evidence and recommendations. Environ Health: Global Access Sci Source 2007;6:22
   PubMed Web of Science ®Google Scholar
• Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology 2001;108:1400–1408
   Google Scholar
• Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, Papoz L. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. Am J Epidemiol 2000;151:497–504
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE, Meuer SM. Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataracts. Am J Ophthalmol 2003;136:506–512
   PubMed Web of Science ®Google Scholar
• Lindblad BE, Hakansson N, Svensson H, Philipson B, Wolk A. Intensity of smoking and smoking cessation in relation to risk of cataract extraction: a prospective study of women. Am J Epidemiol 2005;162:73–79
   PubMed Web of Science ®Google Scholar
• Chylack LT Jr, Brown NP, Bron A, Hurst M, Kopcke W, Thien U, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49–80
   PubMed Web of Science ®Google Scholar
• Taylor A, Jacques PF, Chylack LT Jr, Hankinson SE, Khu PM, Rogers G, et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 2002;75:540–549
   PubMed Web of Science ®Google Scholar
• Jacques PF, Chylack LT, Jr Hankinson SE, Khu PM, Rogers G, Friend J, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001;119:1009–1019
   PubMed Web of Science ®Google Scholar
• Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol 2001;132:19–26
   PubMed Web of Science ®Google Scholar
• Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology 2000;107:450–456
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hyman L, Sperduto R, Underwood B, Chylack LT, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113:1113–1119
   PubMedGoogle Scholar
• Mares-Perlman JA, Brady WE, Klein BE, Klein R, Haus GJ, Palta M, et al. Diet and nuclear lens opacities. Am J Epidemiol 1995;141:322–334
   PubMed Web of Science ®Google Scholar
• Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women. Am J Clin Nutr 2010;91:487–493
   PubMed Web of Science ®Google Scholar
• Mathew MC, Ervin AM, Tao J, Davis RM. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database Syst Rev 2012;6:CD004567
   Google Scholar
• Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris FL, 3rd Colton T, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol 1997;115:1113–1118
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Linton KL, Franke T. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prevent Med 1993;9:27–30
   PubMed Web of Science ®Google Scholar
• West S, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989;107:1166–1169
   PubMed Web of Science ®Google Scholar
• Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012;380:668–679
   PubMed Web of Science ®Google Scholar
• Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 1997;145:242–249
   PubMed Web of Science ®Google Scholar
• Freeman EE, Munoz B, Schein OD, West SK. Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch Ophthalmol 2001;119:1687–1692
   PubMed Web of Science ®Google Scholar
• Klein BE. Lens opacities in women in Beaver Dam, Wisconsin: is there evidence of an effect of sex hormones? Trans Am Ophthalmol Soc 1993;91:517–544
   PubMedGoogle Scholar
• Klein BE, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 1994;112:85–91
   PubMed Web of Science ®Google Scholar
• Younan C, Mitchell P, Cumming RG, Panchapakesan J, Rochtchina E, Hales AM. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Epidemiol 2002;155:997–1006
   PubMed Web of Science ®Google Scholar
• Kanthan GL, Wang JJ, Burlutsky G, Rochtchina E, Cumming RG, Mitchell P. Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains Eye Study. Acta Ophthalmol 2010;88:773–778
   Google Scholar
• Worzala K, Hiller R, Sperduto RD, Mutalik K, Murabito JM, Moskowitz M, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med 2001;161:1448–1454
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol 2000;130:322–326
   PubMed Web of Science ®Google Scholar
• Defay R, Pinchinat S, Lumbroso S, Sultan C, Papoz L, Delcourt C. Relationships between hormonal status and cataract in french postmenopausal women: the POLA study. Ann Epidemiol 2003;13:638–644
   PubMed Web of Science ®Google Scholar
• Lindblad BE, Hakansson N, Philipson B, Wolk A. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women. Ophthalmology 2010;117:424–430
   PubMed Web of Science ®Google Scholar
• Aina FO, Smeeth L, Hubbard R, Hurt LS, Fletcher AE. Hormone replacement therapy and cataract: a population-based case-control study. Eye (Lond) 2006;20:417–422
   PubMed Web of Science ®Google Scholar
• Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78:146–153
   PubMedGoogle Scholar
• Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod 2014;20:76–105
   Google Scholar
• Sperduto RD, Hiller R. The prevalence of nuclear, cortical and posterior subcapsular lens opacities in a general population sample. Ophthalmology 1984;91:815–818
   PubMed Web of Science ®Google Scholar
• Guyton AC. Textbook of medical physiology. Philadelphia: W.B. Saunders Company; 1991
   Google Scholar
• Ginsburg ES, Gao X, Shea BF, Barbieri RL. Half-life of estradiol in postmenopausal women. Gynecol Obstet Invest 1998;45:45–48
   PubMedGoogle Scholar
• Beebe-Dimmer J, Morgenstern H, Cetin K, Yee C, Bartoces M, Shahinian V, et al. Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States. Ann Epidemiol 2011;21:156–163
   Google Scholar
• Jensen EV. On the mechanism of estrogen action. Persp Biol Med 1962;6:47–59
   PubMedGoogle Scholar
• Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986;320:134–139
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925–5930
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508–1510
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863–870
   PubMed Web of Science ®Google Scholar
• O'Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 2004;18:1859–1875
   PubMedGoogle Scholar
• Cheskis BJ, Greger JG, Nagpal S, Freedman LP. Signaling by estrogens. J Cell Physiol 2007;213:610–617
   PubMed Web of Science ®Google Scholar
• Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311–317
   PubMed Web of Science ®Google Scholar
• Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, et al. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000;275:5379–5387
   PubMed Web of Science ®Google Scholar
• Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 2010;24:709–721
   PubMed Web of Science ®Google Scholar
• Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen signaling via estrogen receptor {beta}. J Biol Chem 2010;285:39575–39579
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci 2008;29:116–123
   PubMed Web of Science ®Google Scholar
• Bigsby RM, Cardenas H, Caperell-Grant A, Grubbs CJ. Protective effects of estrogen in a rat model of age-related cataracts. Proc Natl Acad Sci USA 1999;96:9328–9332
   PubMed Web of Science ®Google Scholar
• Kirker MR, Gallagher KM, Witt-Enderby PA, Davis VL. High affinity nuclear and nongenomic estradiol binding sites in the human and mouse lens. Exp Eye Res 2013;112:1–9
   Google Scholar
• Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906–1911
   PubMed Web of Science ®Google Scholar
• Cascio C, Russo D, Drago G, Galizzi G, Passantino R, Guarneri R, et al. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 2007;85:166–172
   PubMed Web of Science ®Google Scholar
• Gorin MB, Day R, Costantino JP, Fisher B, Redmond CK, Wickerham L, et al. Long-term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 1998;125:493–501
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Jacob TJ, Valverde MA, Hardy SP, Mintenig GM, Sepulveda FV, et al. Tamoxifen blocks chloride channels. A possible mechanism for cataract formation. J Clin Invest 1994;94:1690–1697
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Jacob TJ. Volume regulation in the bovine lens and cataract. The involvement of chloride channels. J Clin Invest 1996;97:971–978
   PubMed Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs PD. World population prospects: the 2010 revision, highlights and advance tables; 2011
   Google Scholar
• Fernandez Ballesteros R, Diez Nicolas J, Ruiz Torres A. Aging in Europe. Washington, DC: IOS Press; 1999
   Google Scholar
• Austad SN. Why women live longer than men: sex differences in longevity. Gender Med 2006;3:79–92
   PubMedGoogle Scholar
• Arias E. United States life tables, 2004. National Vital Statistics Reports. Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System; 2007. Vol. 56, pp 1–39
   Google Scholar
• Candore G, Balistreri CR, Listi F, Grimaldi MP, Vasto S, Colonna-Romano G, et al. Immunogenetics, gender, and longevity. Ann NY Acad Sci 2006;1089:516–537
   PubMed Web of Science ®Google Scholar
• Davis P, Graham P, Pearce N. Health expectancy in New Zealand, 1981–1991: social variations and trends in a period of rapid social and economic change. J Epidemiol Commun Health 1999;53:519–527
   Google Scholar
• Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009;374:1196–1208
   PubMed Web of Science ®Google Scholar
• Clutton-Brock TH, Isvaran K. Sex differences in ageing in natural populations of vertebrates. Proc R Soc: Biol Sci 2007;274:3097–3104
   Google Scholar
• Barrett EL, Richardson DS. Sex differences in telomeres and lifespan. Aging Cell 2011;10:913–921
   PubMed Web of Science ®Google Scholar
• Vitale C, Fini M, Speziale G, Chierchia S. Gender differences in the cardiovascular effects of sex hormones. Fundam Clin Pharmacol 2010;24:675–685
   PubMed Web of Science ®Google Scholar
• Novella S, Dantas AP, Segarra G, Medina P, Hermenegildo C. Vascular Aging in women: is estrogen the fountain of youth? Front Physiol 2012;3:165
   PubMed Web of Science ®Google Scholar
• Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertension 2011;24:740–749
   PubMed Web of Science ®Google Scholar
• Hamilton JB, Mestler GE. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J Gerontol 1969;24:395–411
   PubMedGoogle Scholar
• Min KJ, Lee CK, Park HN. The lifespan of Korean eunuchs. Curr Biol 2012;22:R792–R793
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101:485–512
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489–1499
   PubMed Web of Science ®Google Scholar
• Gridley KE, Green PS, Simpkins JW. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 1997;778:158–165
   Google Scholar
• Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651–2662
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947–2958
   PubMed Web of Science ®Google Scholar
• Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103–105
   PubMed Web of Science ®Google Scholar
• Maki PM, Henderson VW. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Climacteric 2012;15:256–262
   PubMed Web of Science ®Google Scholar
• Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298–300
   PubMedGoogle Scholar
• Cutler RG. Peroxide-producing potential of tissues: inverse correlation with longevity of mammalian species. Proc Natl Acad Sci USA 1985;82:4798–4802
   PubMed Web of Science ®Google Scholar
• Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994;263:1128–1130
   PubMed Web of Science ®Google Scholar
• Miquel J, Economos AC, Fleming J, Johnson JE, Jr. Mitochondrial role in cell aging. Exper Gerontol 1980;15:575–591
   PubMed Web of Science ®Google Scholar
• Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003;34:546–552
   PubMed Web of Science ®Google Scholar
• Kumar S, Lata K, Mukhopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. Biochim Biophys Acta 2010;1800:1127–1135
   PubMed Web of Science ®Google Scholar
• Yager JD, Chen JQ. Mitochondrial estrogen receptors – new insights into specific functions. Trends Endocrinol Metab 2007;18:89–91
   PubMed Web of Science ®Google Scholar
• Stirone C, Duckles SP, Krause DN, Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005;68:959–965
   PubMed Web of Science ®Google Scholar
• Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 1999;96:8867–8872
   PubMed Web of Science ®Google Scholar
• Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 1997;63:229–235
   PubMed Web of Science ®Google Scholar
• Miller CP, Jirkovsky I, Hayhurst DA, Adelman SJ. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 1996;61:305–308
   Google Scholar
• Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995;214:847–855
   PubMed Web of Science ®Google Scholar
• Alexaki VI, Charalampopoulos I, Kampa M, Vassalou H, Theodoropoulos P, Stathopoulos EN, et al. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J 2004;18:1594–1596
   PubMed Web of Science ®Google Scholar
• Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J Mol Endocrinol 2009;43:251–261
   Google Scholar
• Axelrod N. Of telomeres and tumors. Nat Med 1996;2:158–159
   PubMedGoogle Scholar
• Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Gene 1996;18:173–179
   PubMedGoogle Scholar
• Meeker AK, Coffey DS. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochem Biokhimiia 1997;62:1323–1331
   PubMed Web of Science ®Google Scholar
• Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol 2007;3:640–649
   PubMed Web of Science ®Google Scholar
• Stindl R. Tying it all together: telomeres, sexual size dimorphism and the gender gap in life expectancy. Med Hypotheses 2004;62:151–154
   PubMed Web of Science ®Google Scholar
• Gardner M, Bann D, Wiley L, Cooper R, Hardy R, Nitsch D, et al. Gender and telomere length: Systematic review and meta-analysis. Exp Gerontol 2014;51:15--27
   PubMed Web of Science ®Google Scholar
• Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, et al. Estrogen activates telomerase. Cancer Res 1999;59:5917–5921
   PubMed Web of Science ®Google Scholar
• Hales AM, Chamberlain CG, Murphy CR, McAvoy JW. Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta). J Exper Med 1997;185:273–280
   PubMed Web of Science ®Google Scholar
• Bigsby RM, Valluri S, Lopez J, Mendonca MS, Caperell-Grant A, DesRosiers C, et al. Ovarian hormone modulation of radiation-induced cataractogenesis: dose-response studies. Invest Ophthalmol Vis Sci 2009;50:3304–3310
   PubMed Web of Science ®Google Scholar
• Davis VL, Chan CC, Schoen TJ, Couse JF, Chader GJ, Korach KS. An estrogen receptor repressor induces cataract formation in transgenic mice. Proc Natl Acad Sci USA 2002;99:9427–9432
   Google Scholar
• Colitz CM, Davidson MG, McGahan GM. Telomerase activity in lens epithelial cells of normal and cataractous lenses. Exp Eye Res 1999;69:641–649
   PubMed Web of Science ®Google Scholar
• Colitz CM, Whittington A, Carter R, Warren J. The effects of oxidative stress on telomerase activity and other stress-related proteins in lens epithelial cells. Exp Eye Res 2004;78:235–242
   Google Scholar
• Colitz CM, Sugimoto Y, Lu P, Barden CA, Thomas-Ahner J, Chandler HL. ERalpha increases expression and interacts with TERT in cataractous canine lens epithelial cells. Mol Vis 2009;15:2259–2267
   Google Scholar
• Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond Ser B, Biol Sci 2011;366:1278–1292
   PubMed Web of Science ®Google Scholar
• Beebe DC, Holekamp NM, Shui YB. Oxidative damage and the prevention of age-related cataracts. Ophthalmic Res 2010;44:155–165
   PubMed Web of Science ®Google Scholar
• Celojevic D, Petersen A, Karlsson JO, Behndig A, Zetterberg M. Effects of 17beta-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cells. Mol Vis 2011;17:1987–1996
   PubMed Web of Science ®Google Scholar
• Gajjar D, Patel D, Alapure B, Praveen MR, Patel A, Johar K, Sr et al. Rapid action of oestradiol against hydrogen peroxide-induced oxidative stress in cataractous lens epithelium: an in vitro study. Eye (Lond) 2009;23:1456–1463
   PubMed Web of Science ®Google Scholar
• Wang X, Simpkins JW, Dykens JA, Cammarata PR. Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci 2003;44:2067–2075
   PubMed Web of Science ®Google Scholar
• Cammarata PR, Chu S, Moor A, Wang Z, Yang SH, Simpkins JW. Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp Eye Res 2004;78:861–871
   PubMed Web of Science ®Google Scholar
• Cammarata PR, Flynn J, Gottipati S, Chu S, Dimitrijevich S, Younes M, et al. Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Exp Eye Res 2005;81:165–175
   PubMed Web of Science ®Google Scholar
• Flynn JM, Dimitrijevich SD, Younes M, Skliris G, Murphy LC, Cammarata PR. Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab 2008;295:E637–647
   PubMed Web of Science ®Google Scholar
• Moor AN, Flynn JM, Gottipati S, Giblin FJ, Cammarata PR. 17beta-estradiol stimulates MAPK signaling pathway in human lens epithelial cell cultures preventing collapse of mitochondrial membrane potential during acute oxidative stress. Mitochondrion 2005;5:235–247
   PubMed Web of Science ®Google Scholar
• Flynn JM, Lannigan DA, Clark DE, Garner MH, Cammarata PR. RNA suppression of ERK2 leads to collapse of mitochondrial membrane potential with acute oxidative stress in human lens epithelial cells. Am J Physiol Endocrinol Metab 2008;294:E589–599
   Google Scholar
• Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005;579:2541–2545
   PubMed Web of Science ®Google Scholar
• Gottipati S, Cammarata PR. Mitochondrial superoxide dismutase activation with 17 beta-estradiol-treated human lens epithelial cells. Mol Vis 2008;14:898–905
   PubMed Web of Science ®Google Scholar
• Pedram A, Razandi M, Wallace DC, Levin ER. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 2006;17:2125–2137
   PubMed Web of Science ®Google Scholar
• Razmara A, Duckles SP, Krause DN, Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res 2007;1176:71–81
   PubMed Web of Science ®Google Scholar
• Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003;93:170–177
   PubMed Web of Science ®Google Scholar
• Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 2005;4:113–118
   PubMed Web of Science ®Google Scholar
• Giddabasappa A, Bauler M, Yepuru M, Chaum E, Dalton JT, Eswaraka J. 17-beta estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-beta. Invest Ophthalmol Vis Sci 2010;51:5278–5287
   Google Scholar
• Razmara A, Sunday L, Stirone C, Wang XB, Krause DN, Duckles SP, et al. Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. J Pharmacol Exp Ther 2008;325:782–790
   PubMed Web of Science ®Google Scholar
• Chen KC, Zhou Y, Xing K, Krysan K, Lou MF. Platelet derived growth factor (PDGF)-induced reactive oxygen species in the lens epithelial cells: the redox signaling. Exp Eye Res 2004;78:1057–1067
   PubMed Web of Science ®Google Scholar
• Santen RJ, Allred DC. The estrogen paradox. Nat Clin Practice: Endocrinol Metab 2007;3:496–497
   PubMedGoogle Scholar
• Zetterberg M, Petersen A, Karlsson J-O, Sundelin K. Proliferation of cultured lens epithelial cells and association with possible risk factors for posterior capsular opacification. Acta Ophthalmol 2010;88:S246
   Google Scholar
• Ninn-Pedersen K, Bauer B. Cataract patients in a defined Swedish population 1986–1990. VI. YAG laser capsulotomies in relation to preoperative and surgical conditions. Acta Ophthalmol Scand 1997;75:551–557
   PubMedGoogle Scholar